In today’s fast-paced world, the pharmaceutical industry is constantly evolving to keep up with the latest technologies. Artificial intelligence is playing a significant role in shaping the future of medicine, with leaders like AstraZeneca’s CFO Aradhana Sarin at the forefront of this transformation.
Aradhana Sarin, Executive Director & Global Chief Financial Officer at AstraZeneca, has been instrumental in leading the company’s efforts to embrace technology and advance modern medicine. In 2023, AstraZeneca launched its health-tech division Evinova, utilizing digital technology to enhance clinical trials and medicine delivery processes. This innovative approach aims to make bringing new treatments to market more efficient and accessible to patients.
Furthermore, AstraZeneca’s strategic acquisition of preclinical gene therapy programs from Pfizer in 2023 underscores the company’s commitment to addressing rare diseases. With about 80% of rare diseases being genetic-based, gene therapy holds the potential to cure these illnesses and revolutionize healthcare.
Sarin, who took on the CFO role at AstraZeneca in 2022, brings a diverse background to her leadership position. With experience in biopharma, investment banking, and medical practice, she offers a unique perspective on the business that has proven invaluable in driving strategic decisions and resource allocation.
As a changemaker in the industry, Aradhana Sarin’s accomplishments exemplify the impact that women are making in the business world. Her dedication to leveraging technology and innovation in healthcare is paving the way for a brighter future in medicine.
To read more inspiring stories of women making a mark in business, check out our annual list of Changemakers. Join us in celebrating their achievements and continued success in shaping the future of industries worldwide.
Source link